BK3014 Healthcare Providers & Services
- 27381609.231
- -34965.239-0.13%
CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.35 From SG$0.32, Keeps at Add
CGS-CIMB Research Adjusts Raffles Medical Group's Price Target to SG$1.16 From SG$1.20, Keeps at Buy
Analysts Offer Insights on Healthcare Companies: Raffles Medical Group (OtherRAFLF), Agilent (A) and Karuna Therapeutics (KRTX)
CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.32 From SG$0.34, Keeps at Add
Maybank Securities Downgrades Raffles Medical Group to Hold From Buy, Adjusts Price Target to SG$1.30 From SG$1.65
Hold Rating on Raffles Medical Group Amid Declining Profits and Rising Operational Costs
Nomura Adjusts Raffles Medical's Price Target to SG$1.40 From SG$1.60, Keeps at Buy
Raffles Medical Group's Strategic Expansion and Growth Potential: A Buy Recommendation
UOB Kay Hian Keeps Their Buy Rating on Raffles Medical Group (RAFLF)
PhillipCapital Downgrades Q & M Dental to Accumulate From Buy, Adjusts Price Target to SG$0.34 From SG$0.47
CGS-CIMB Remains a Buy on Raffles Medical Group (RAFLF)
Raffles Medical Group (RAFLF) Receives a Buy From UOB Kay Hian
Analysts Are Bullish on These Healthcare Stocks: Raffles Medical Group (RAFLF), Evolent Health (EVH)
Raffles Medical Group (RAFLF) Gets a Buy From RHB Capital
Raffles Medical Group (RAFLF) Receives a Buy From RHB Capital
RHB Capital Sticks to Its Buy Rating for Raffles Medical Group (RAFLF)
Analysts Are Bullish on Top Healthcare Stocks: Raffles Medical Group (RAFLF), IN8bio (INAB)
UOB Kay Hian Sticks to Their Buy Rating for Raffles Medical Group (RAFLF)
DBS Adjusts Q & M Dental's Price Target to SG$0.36 From SG$0.40, Keeps at Hold
Phillip Securities Keeps Their Buy Rating on Raffles Medical Group (RAFLF)